Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 Alleles

Human Immunology

Volumn 64, Issue 4, 2003, Pages 440-452

  Lacey, Simon F ^a   Villacres, Maria C ^a,c   La Rosa, Corinna ^a   Wang, Zhongde ^a   Longmate, Jeff ^a   Martinez, Joybelle ^a   Brewer, John C ^a   Mekhoubad, Shahram ^a   Maas, Rebecca ^a   Leedom, John M ^b   Forman, Stephen J ^a   Zaia, John A ^a   Diamond, Don J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b LAC USC MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

CTL; Cytomegalovirus; HLA; Immunodominance; MHC I

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA A2 ANTIGEN; HLA B7 ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS ANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PROCESSING; STEM CELL TRANSPLANTATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0037381949     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(03)00028-4     Document Type: Article

References (42)

1. Rammensee HG, Friede T, Stevanoviic S: MHC ligands and peptide motifs: first listing. Immunogenetics 41:178, 1995.
2. Pamer E, Cresswell P: Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 16:323, 1998.
3. Yewdell JW, Bennink JR: Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 17:51, 1999.
4. Niedermann G, Butz S, Ihlenfeldt HG, Grimm R, Lucchiari M, Hoschutzky H, Jung G, Maier B, Eichmann K: Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289, 1995.
5. Uebel S, Meyer TH, Kraas W, Kienle S, Jung G, Wiesmuller KH, Tampe R: Requirements for peptide binding to the human transporter associated with antigen processing revealed by peptide scans and complex peptide libraries. J Biol Chem 270:18512, 1995.
6. Anderson K, Cresswell P, Gammon M, Hermes J, Williamson A, Zweerink H: Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis. J Exp Med 174:489, 1991.
7. Snyder HL, Yewdell JW, Bennink JR: Trimming of antigenic peptides in an early secretory compartment. J Exp Med 180:2389, 1994.
8. Tanaka K, Tanahashi N, Tsurumi C, Yokota KY, Shimbara N: Proteasomes and antigen processing. Adv Immunol 64:1, 1997.
9. Sette A, Sidney J, Del Guercio MF, Southwood S, Ruppert J, Dahlberg C, Grey HM, Kubo RT: Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol Immunol 31: 813, 1994.
10. Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJ, Oseroff C, Yuan L, Ruppert J: The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 153:5586, 1994.
11. Hollsberg P: Contribution of HLA class I allele expression to CD8+ T-cell responses against Epstein-Barr virus. Scand J Immunol 55:189, 2002.
12. Day CL, Shea AK, Altfeld MA, Olson DP, Buchbinder SP, Hecht FM, Rosenberg ES, Walker BD, Kalams SA: Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles. J Virol 75: 6279, 2001.
13. Diamond DJ, York J, Sun J, Wright CL, Forman SJ: Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood 90:1751, 1997.
14. Longmate J, York J, La Rosa C, Krishnan R, Zhang M, Senitzer D, Diamond DJ: Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes. Immunogenetics 52:165, 2001.
15. Krausa P, Browning MJ: A comprehensive PCR-SSP typing system for identification of HLA-A locus alleles. Tissue Antigens 47:237, 1996.
16. La Rosa C, Lacey SF, Brewer JC, Lacey SF, Villacres MC, Sharan R, Krishnan R, Crooks M, Markel S, Maas R, Diamond DJ. Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice. Blood 100:3681, 2002.
17. Altman JD, Moss PAH, Goulder PJR, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM: Phenotypic analysis of antigen-specific T lymphocytes [published erratum appears in Science 280:1821, 1998]. Science 274:94, 1996.
18. Rosenberg AH, Lade BN, Chui DS, Lin SW, Dunn JJ, Studier FW: Vectors for selective expression of cloned DNAs by T7 RNA polymerase. Gene 56:125, 1987.
19. Rickinson AB, Rowe M, Hart IJ, Yao QY, Henderson LE, Rabin H, Epstein MA: T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. Cell Immunol 87:646, 1984.
20. Lubaki MN, Egan MA, Siliciano RF, Weinhold KJ, Bollinger RC: A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. AIDS Res Hum Retroviruses 10:1427, 1994.
21. Tobery TW, Siliciano RF: Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J Exp Med 185:909, 1997.
22. Earl PL, Moss B: Expression of proteins in mammalian cells using vaccinia viral vectors. In Ausubel FM, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds): Current Protocols in Molecular Biology. New York: Greene/Wiley Interscience, 1998.
23. Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, Plachter B, Sissons JG: The human CTL response to cytomegalovirus is dominanted by structural protein pp65: frequency, specificity, and T cell receptor usage of pp65-specific CTL. J Virol 70:7569, 1996.
24. La Rosa C, Krishnan R, Markel S, Schneck JP, Houghten R, Pinilla C, Diamond DJ: Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries. Blood 97:1776, 2001.
25. Lacey SF, Gallez-Hawkins G, Crooks M, Martinez J, Senitzer D, Forman SJ, Spielberger R, Zaia JA, Diamond DJ: Characterization of cytotoxic function of CMV p65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplants. Transplantation 74:722, 2002.
26. Agresti A: Categorical Data Analysis. New York: Wiley, 1990.
27. Khan N, Cobbold M, Keenan R, Moss PA: Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype. J Infect Dis 185:1025, 2002.
28. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, Nayak L, Moss PA: Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 169: 1984, 2002.
29. Hebart H, Daginik S, Stevanovic S, Grigoleit U, Dobler A, Baur M, Rauser G, Sinzger C, Jahn G, Loeffler J, Kanz L, Rammensee HG, Einsele H: Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation. Blood 99:3830, 2002.
30. Khanna R, Burrows SR, Neisig A, Neefjes J, Moss DJ, Silins SL: Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines. J Virol 71:7429, 1997.
31. Varshavsky A: The N-end rule: functions, mysteries, uses. Proc Natl Acad Sci USA 93:12142, 1996.
32. Liu WJ, Zhao KN, Gao FG, Leggatt GR, Fernando GJ, Frazer IH: Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Vaccine 20:862, 2001.
33. Ye M, Morello CS, Spector DH: Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent vital challenge. J Virol 76:2100, 2002.
34. Burrows SR, Silins SL, Moss DJ, Khanna R, Misko IS, Argaet VP: T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J Exp Med 182:1703, 1995.
35. Burrows SR, Khanna R, Burrows JM, Moss DJ: An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J Exp Med 179:1155, 1994.
36. Eberl G, Kessler B, Eberl LP, Brunda MJ, Valmori D, Corradin G: Immunodominance of cytotoxic T lymphocyte epitopes co-injected in vivo and modulation by interleukin-12. Eur J Immunol 26:2709, 1996.
37. Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL: The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769, 1996.
38. Jones TR, Sun L: Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J Virol 71:2970, 1997.
39. Jones TR, Wiertz EJ, Sun L, Fish KN, Nelson JA, Ploegh HL: Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci USA 93:11327, 1996.
40. Hengel H, Koopmann JO, Flohr T, Muranyi W, Goulmy E, Hammerling GJ, Koszinowski UH, Momburg F: A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6:623, 1997.
41. Lehnet PJ, Karttunen JT, Wilkinson GW, Cresswell P: The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci USA 94:6904, 1997.
42. Weidt G, Utermohlen O, Heukeshoven J, Lehmann-Grube F, Deppert W: Relationship among immunodominance of single CD8+ T cell epitopes, virus load, and kinetics of primary antiviral CTL response. J Immunol 160:2923, 1998.